Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.560
+0.100 (6.85%)
At close: Oct 9, 2026, 4:00 PM EDT
1.530
-0.030 (-1.92%)
After-hours: Oct 9, 2026, 7:55 PM EDT
Celularity Revenue
Celularity had revenue of $3.85M in the quarter ending March 31, 2026, a decrease of -66.34%. This brings the company's revenue in the last twelve months to $18.97M, down -62.78% year-over-year. In the year 2025, Celularity had annual revenue of $26.55M, down -51.03%. That makes Celularity the 34,087th largest company in the world by revenue and 4,488th in the United States.
Revenue (ttm)
$18.97M
Revenue Growth
-62.78%
P/S Ratio
2.67
Revenue / Employee
$164,957
Employees
115
Market Cap
50.62M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.55M | -27.67M | -51.03% |
| Dec 31, 2024 | 54.22M | 31.45M | 138.11% |
| Dec 31, 2023 | 22.77M | 4.80M | 26.68% |
| Dec 31, 2022 | 17.98M | -3.36M | -15.75% |
| Dec 31, 2021 | 21.34M | 7.06M | 49.43% |
| Dec 31, 2020 | 14.28M | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 34.59M |
| Apollomics | 8.84M |
| ImageneBio | 800.00K |
| CervoMed | 331.30K |
| Serina Therapeutics | 130.00K |
| INmune Bio | 50.00K |
| eXoZymes | -700.00 |
CELU News
- 9 days ago - Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner - GlobeNewsWire
- 10 days ago - Celularity announces Jain to join Board of Directors - TheFly
- 10 days ago - Celularity Announces Naveen Jain to Join Board of Directors - GlobeNewsWire
- 10 days ago - Celularity Quarterly report: Q1 2026 - Filings
- 15 days ago - Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements - GlobeNewsWire
- 6 weeks ago - Why Is Penny Stock Celularity (CELU) Up 115% Today? - TipRanks
- 6 weeks ago - Celularity, MuseCell Innovations announce U.S. manufacturing collaboration - TheFly
- 6 weeks ago - Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform - Business Wire